Nicotine Salts and Synthetic Nicotine: New Challenges for an Old Problem
DOI:
https://doi.org/10.32635/2176-9745.RBC.2022v68n4.2846Keywords:
tobacco use disorder, nicotine, electronic nicotine delivery systems, smoking cessation, control and sanitary supervision of tobacco-derived productsAbstract
Smoking is recognized as a chronic disease caused by dependence on nicotine present in tobacco products. and is linked to a number of tobacco related diseases. In addition to this, it is considered a pediatric disease. In Brazil, treatment for smoking cessation since 2004 is offered at all levels of complexity by the National Health System (SUS), however the existing protocols internationally used seems to have significant limitations when used in populations like children and adolescents. Nicotine salts have a lower degree of irritation and impact in the throat and mouth caused by nicotine, enabling the use of higher concentrations of nicotine. Synthetic nicotine has shown itself to be more economically viable every day and there are already products on the market that use this form of nicotine, however few studies have been conducted to assess its health impacts. The new forms of nicotine and its synthetic form, associated with products with an attractive design, especially for the youngest, bring considerable technical challenges to health professionals, as effective protocols to treat nicotine dependence arising from these new forms of use are currently unknown.
Downloads
References
Instituto Nacional de Câncer. Rio de Janeiro: INCA; [data desconhecida]. Tabagismo; 2022 jun 6 [atualizado 2022 ago 31; acesso 2022 abr 7]. Disponível em: https://www.inca.gov.br/tabagismo
Loddenkemper R, Kreuter M, editors. The tobacco epidemic. 2nd. Basel (SWI): Karger; 2015. (Progress in Respiratory Research; 42).
Committee on Environmental Health; Committee on Substance Abuse; Committee on Adolescence; Committee on Native American Child Health. Tobacco use: a pediatric disease. Pediatrics. 2009 Nov 1;124(5):1474-87. doi: https://doi.org/10.1542/peds.2009-2114
Ministério da Saúde (BR), Secretaria de Atenção Especializada à Saúde, Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Portaria Conjunta nº 10, de 16 de abril de 2020. Aprova o Protocolo Clínico e Diretrizes Terapêuticas do Tabagismo [Internet]. Diário Oficial da União, Brasília, DF. 2020 abr 24 [acesso 2022 jul 1]; Seção 1:214. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//protocolo-clinico-e-diretrizes-terapeuticas-do-tabagismo.pdf
Leslie FM. Unique, long-term effects of nicotine on adolescent brain. Pharmacol Biochem Behav. 2020;197:173010. doi: https://doi.org/10.1016/j.pbb.2020.173010
Silva ALO, Moreira JC, Silva ALO, et al. Por que os cigarros eletrônicos são uma ameaça à saúde pública? Cad Saúde Pública. 2019;35(6):e00246818. doi: https://doi.org/10.1590/0102-311X00246818
National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health. Preventing tobacco use among youth and young adults: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2012 [cited 2016 May 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK99237
Duell AK, Pankow JF, Peyton DH. Nicotine in tobacco product aerosols: ‘It’s déjà vu all over again’. Tob Control. 2020;29(6):656-62. doi: http://doi.org/10.1136/tobaccocontrol-2019-055275
Prochaska JJ, Vogel EA, Benowitz N. Nicotine delivery and cigarette equivalents from vaping a JUULpod. Tob Control. 2022;31(e1):e88-e93. doi: http://doi.org/10.1136/tobaccocontrol-2020-056367
Hammond D, Wackowski OA, Reid JL, et al. Use of Juul e-cigarettes among youth in the United States. Nicotine Tob Res. 2018;22(5):827-32. doi: https://doi.org/10.1093/ntr/nty237
Martins SR. Nicotina: o que sabemos? [Internet]. São Paulo: ACT Promoção da Saúde; 2022 [acesso 2022 jul 1]. (Nota Técnica sobre a Nicotina). Disponível em: https://actbr.org.br/uploads/arquivos/ACT-Nicotina-NotaTecnica-%284%29.pdf
Stratton K, Kwan LY, Eaton DL, editors. Public health consequences of e-cigarettes [Internet]. Washington (DC): National Academies Press; 2018 [cited 2022 Apr 7]. Available from: https://sbpt.org.br/portal/wp-content/uploads/2020/11/2018-ecig-nacional-academy.pdf
Adams J. Surgeon general’s advisory on e-cigarette use among youth [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2018 Dec [cited 2022 Apr 7]. Available from: https://e-cigarettes.surgeongeneral.gov/documents/surgeon-generals-advisory-on-e-cigarette-use-among-youth-2018.pdf
King BA, Gammon DG, Marynak KL, et al. Electronic cigarette sales in the United States, 2013-2017. JAMA. 2018;320(13):1379-80. doi: https://doi.org/10.1001/jama.2018.10488
Primack BA, Shensa A, Sidani JE, et al. Initiation of traditional cigarette smoking after electronic cigarette use among tobacco-naïve US young adults. Am J Med. 2018;131(4):443.e1-443.e9. doi: https://doi.org/10.1016/j.amjmed.2017.11.005
Chadi N, Schroeder R, Jensen JW, et al. Association between electronic cigarette use and marijuana use among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(10):e192574. doi: https://doi.org/10.1001/jamapediatrics.2019.2574
Hershberger A, Argyriou E, Cyders M. Electronic nicotine delivery system use is related to higher odds of alcohol and marijuana use in adolescents: meta-analytic evidence. Addict Behav. 2020;105:106325. doi: https://doi.org/10.1016/j.addbeh.2020.106325
Chan GCK, Stjepanović D, Lim C, et al. Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation. Addiction. 2021;116(4):743-56. doi: https://doi.org/10.1111/add.15246
Burt B, Li J. The electronic cigarette epidemic in youth and young adults: a practical review. JAAPA. 2020;33(3):17-23. doi: https://doi.org/10.1097/01.JAA.0000654384.02068.99
Hartmann-Boyce J, McRobbie H, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021;9:CD010216. doi: https://doi.org/10.1002/14651858.CD010216.pub6
American Tobacco [Internet]. London: BAT; [date unknown]. Vapour products; [cited 2022 Sept 2]. Available from: https://www.bat.com/ecigarettes#
Hanewinkel R, Niederberger K, Pedersen A, et al. E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials. Eur Respir Rev. 2022;31(163):210215. doi: https://doi.org/10.1183/16000617.0215-2021
Banks E, Yazidjoglou A, Brown S, et al. Electronic cigarettes and health outcomes: systematic review of global evidence. Canberra (AU): National Centre for Epidemiology and Population Health; 2022 Apr 7. doi: https://doi.org/10.25911/XV0F-6C42
Kaur G, Muthumalage T, Rahman I. Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products. Toxicol Lett. 2018;288:143-55. doi: https://doi.org/10.1016/j.toxlet.2018.02.025
Jordt SE. Synthetic nicotine has arrived. Tob Control. 2021;tobaccocontrol-2021-056626. doi: https://doi.org/10.1136/tobaccocontrol-2021-056626
Tobacco Reporter [Internet]. Raleigh (NC): Tobacco Reporter; c2020. Rossel S. Synthetic nicotine is gaining acceptance; 2019 Dec 1 [cited 2022 Apr 5]. Available from: https://tobaccoreporter.com/2019/12/01/mirror-image/
Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71. doi: https://doi.org/10.1146/annurev.pharmtox.48.113006.094742
Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79-115. doi: https://doi.org/10.1124/pr.57.1.3
Aceto MD, Martin BR, Uwaydah IM, et al. Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. J Med Chem. 1979;22(2):174-7. doi: https://doi.org/10.1021/jm00188a009
Abood LG, Grassi S, Costanza M. Binding of optically pure (--)-[3H]nicotine to rat brain membranes. FEBS Lett. 1983;157(1):147-9. doi: https://doi.org/10.1016/0014-5793(83)81134-x
Anderson HD. Manufacture of nicotine [Internet]. San Francisco (CA): Truth Tobacco Industry Documents; 1964 Aug [cited 2022 Jun 21]. 2 p. (British American Tobacco Records); (Bates Number:100048807-100048808 ). Available from: https://www.industrydocuments.ucsf.edu/docs/#id=lgcy0212
Moates RF, Chemical Research, Teague CE. Feasibility of synthetic nicotine production [Internet]. San Francisco (CA): Truth Tobacco Industry Documents; 1967 Sept [cited 2022 Jun 21]. 4 p. (RJ Reynolds Records; Master Settlement Agreement); (Bates Number: 500613486-500613489). Available from: https://www.industrydocuments.ucsf.edu/docs/#id=srhn0096
Southwick EW. Synthesis of nicotine [Internet]. San Francisco (CA): Truth Tobacco Industry Documents; 1978 Jan [cited 2022 Jun 21]. 2 p. (Liggett & Myers Records); (Bates Number: lg0292754-lg0292755). Available from: https://www.industrydocuments.ucsf.edu/docs/#id=gpyw0014
Liquid Nicotine Wholesalers [Internet]. Phoenix (AZ): LNW; c2022. LNW Pure Liquid Nicotine; [cited 2022 Sept 1]. Available from: https://liquidnicotinewholesalers.com/lnw-pure-liquid-nicotine.html
Liquid Nicotine Wholesalers [Internet]. Phoenix (AZ): LNW; c2022. TFN® Pure Nicotine; [cited 2022 Sept 1]. Available from: https://liquidnicotinewholesalers.com/tfn-pure-liquid-nicotine.html
Clemens KJ, Caillé S, Stinus L, et al. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol. 2009;12(10):1355-66. doi: https://doi.org/10.1017/S1461145709000273
Food and Drug Administration [Internet]. Silver Spring (MD): FDA; [date unknown]. Requirements for products made with non-tobacco nicotine take effect April 14; 2022 Apr 13 [cited 2022 Sept 1]. Available from: https://www.fda.gov/tobacco-products/ctp-newsroom/requirements-products-made-non-tobacco-nicotine-take-effect-april-14
Presidência da República (BR). Lei nº 9.294, de 15 de julho de 1996. Dispõe sobre as restrições ao uso e à propaganda de produtos fumígeros, bebidas alcoólicas, medicamentos, terapias e defensivos agrícolas, nos termos do § 4° do art. 220 da Constituição Federal [Internet]. Diário Oficial da União, Brasília, DF. 1996 jul 16 [acesso 2022 jul 1]; Seção 1:13074. Disponível em: http://www.planalto.gov.br/ccivil_03/leis/l9294.htm
Presidência da República (BR). Lei nº de 26 de janeiro de 1999. Define o Sistema Nacional de Vigilância Sanitária, cria a Agência Nacional de Vigilância Sanitária, e dá outras providências [Internet]. Diário Oficial da União, Brasília, DF. 1999 jan 27 [acesso 2022 jul 1]; Seção 1:1. Disponível em: http://www.planalto.gov.br/ccivil_03/leis/l9782.htm
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
